News
Media
Conferences
Publications
Events
CME/CE
Resources
Career Center
Subscribe

Fernando Sabino Marques Monteiro, MD

Articles by Fernando Sabino Marques Monteiro, MD

Use of Immunotherapy in Patients With Cancer During the COVID-19 Pandemic

ByAndrey Soares, MD,Fabio A. Schultz, MD,Diogo Assed Bastos, MD,Deni Leonardo Fontes Jardim, MD, PhD,Fernando Sabino Marques Monteiro, MD

September 22nd 2020

This article discusses the potential implications of using checkpoint inhibitors during the COVID-19 pandemic.

Latest Updated Articles

Use of Immunotherapy in Patients With Cancer During the COVID-19 Pandemic
September 22nd 2020

Trending on CancerNetwork

FDA Approves Vepdegestrant in ER+, HER2–, ESR1-Mutated Breast Cancer

FDA Permits Expanded Daraxonrasib Access in Previously Treated Metastatic PDAC

FDA ODAC Votes Yes to Capivasertib for PTEN-Deficient Metastatic HSPC

Taletrectinib Demonstrates Durable Efficacy in ROS1-Positive NSCLC

Targeting KRAS in Pancreatic Cancer: What Is Daraxonrasib’s Mechanism of Action?